1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Taiwan Pharmaceuticals and Healthcare Report Q4 2016

Taiwan Pharmaceuticals and Healthcare Report Q4 2016

  • October 2016
  • -
  • Business Monitor International
  • -
  • 90 pages

Includes 3 FREE quarterly updates


BMI View:
Taiwan's domestic pharmaceutical sector will seek to grow its exports to South East Asia as part of its attempt to diversify away from the China market. However, successfully implementing this strategy will be tough as competition in the region intensifies, with multinational drugmakers, Indian generic firms and other East Asian pharmaceutical companies expanding their presence in the market. Cooling cross-Strait relations will further hinder efforts to foster trade as China holds significant sway within South East Asia, particularly among the more developing countries.
Headline Expenditure Projections


- Pharmaceuticals: TWD174.8bn (USD5.5bn) in 2015 to TWD181.6bn (USD5.6bn) in 2016; + 3.9% in local currency and 1.9% in US dollar terms.

- Healthcare: TWD1,046.8bn (USD33.0bn) in 2015 to TWD1,090.7bn (USD33.7bn) by 2016; + 4.2% in local currency terms and +2.2% in US dollar terms.

Table Of Contents

Taiwan Pharmaceuticals and Healthcare Report Q4 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Taiwan 2014-2020) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Taiwan 2012-2020) 13
Healthcare Market Forecast 14
Table: Copayments Levels (TWD) 15
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Taiwan 2012-2020) 16
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Taiwan 2012-2020) 17
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Taiwan 2012-2020) 17
Prescription Drug Market Forecast 18
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Taiwan 2012-2020) 20
Patented Drug Market Forecast 21
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Taiwan 2012-2020) 23
Generic Drug Market Forecast 24
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Taiwan 2012-2020) 25
OTC Medicine Market Forecast 26
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Taiwan 2012-2020) 27
Pharmaceutical Trade Forecast 28
Table: Pharmaceutical Trade Data And Forecasts (Taiwan 2014-2020) 29
Table: Pharmaceutical Trade Data And Forecasts local currency (Taiwan 2014-2020) 30
Industry Risk/Reward Index 31
Asia Pacific Risk/Reward Index - Q4 2016 31
Taiwan Risk/Reward Index 38
Rewards 38
Risks 38
Regulatory Review 40
Table: Medicine Categories In Taiwan 41
Table: Examples Of Controlled Drugs In Taiwan 41
Intellectual Property Issues 42
Pricing and Reimbursement Regime 43
Table: Price Adjustments Enacted 43
Market Overview 45
Market Overview 45
Healthcare Sector 45
Table: NHI Premium Contribution Ratios 46
Table: Healthcare Resources (Taiwan 2010-2015) 47
Table: Healthcare Personnel (Taiwan 2010-2015) 47
Table: Healthcare Activity (Taiwan 2010-2015) 48
Clinical Trials 48
Epidemiology 50
Competitive Landscape 54
Research-Based Industry 54
Table: Corporate Member Companies Of IRPMA 54
Table: Multinational Market Activity 55
Generic Drugmakers 56
Table: Members of Taiwan Generic Pharmaceutical Association (As of June 2016) 57
Pharmaceutical Distribution 58
Pharmaceutical Retail Sector 58
Company Profile 60
GlaxoSmithKline (GSK) 60
Merck and Co 63
Novartis 65
Pfizer 68
ScinoPharm Taiwan 70
TaiGen 74
Yung Shin Pharmaceutical (YSP) 77
Demographic Forecast 79
Table: Population Headline Indicators (Taiwan 1990-2025) 80
Table: Key Population Ratios (Taiwan 1990-2025) 80
Table: Urban/Rural Population and Life Expectancy (Taiwan 1990-2025) 81
Table: Population By Age Group (Taiwan 1990-2025) 81
Table: Population By Age Group % (Taiwan 1990-2025) 82
Glossary 84
Methodology 86
Pharmaceutical Expenditure Forecast Model 86
Healthcare Expenditure Forecast Model 86
Notes On Methodology 87
Risk/Reward Index Methodology 88
Index Overview 89
Table: Pharmaceutical Risk/Reward Index Indicators 89
Indicator Weightings 90

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.